OUTLOOK THERAPEUTICS, INC. Notes Issued
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Notes Issued of $7.05 million for the 12-month period ending 2020-09-30, per its 10-K filed 2021-12-23.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2021-12-23
- OUTLOOK THERAPEUTICS, INC. notes issued for the quarter ending 2020-09-30 was $0.00.
- OUTLOOK THERAPEUTICS, INC. notes issued for the quarter ending 2020-06-30 was $0.00.
- OUTLOOK THERAPEUTICS, INC. notes issued for the quarter ending 2020-03-31 was $0.00.
- OUTLOOK THERAPEUTICS, INC. notes issued for the quarter ending 2019-12-31 was $7.05M.
- OUTLOOK THERAPEUTICS, INC. notes issued for fiscal 2020 was $7.05M.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | $0.00 derived: sum of 2 quarters · filed 2021-12-23 | $0.00 derived: sum of 3 quarters · filed 2021-12-23 | $7.05M 10-K · filed 2021-12-23 |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | $0.00 derived: sum of 2 quarters · filed 2021-08-13 | $7.05M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | $7.05M 10-Q · filed 2021-05-14 | ||
| 2019-12-31 | $7.05M 10-Q · filed 2021-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |